AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Assessment of Pro-Resolution Mediator Levels in Periodontitis Stage III and IV Before and After Periodontal Therapy

RecruitingNAAges 18 Years - 80 YearsAllCairo University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This study aims to assess Pro-Resolution Mediator levels during non-surgical periodontal therapy in individuals with Stage III and IV periodontitis, comparing them to healthy subjects. Periodontitis, a chronic inflammatory condition affecting tooth-supporting tissues, can lead to tooth loss and systemic complications. Understanding the role of pro-resolving lipid mediators in inflammation resolution may offer insights into therapeutic benefits associated with these mediators.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: Inclusion criteria: 1. Adult patients above 18 years old. 2. Interdental CAL at site of greatest loss โ‰ฅ5 mm or extending to middle third of the root. 3. Interdental CAL at site of greatest loss โ‰ฅ8 mm or extending to apical third of the root. 4. Probing depth โ‰ฅ6 mm. 5. Vertical bone loss โ‰ฅ3 mm. 6. Tooth loss due to periodontitis of โ‰ค4 teeth. (Periodontitis Stage III) 7. Tooth loss due to periodontitis of โ‰ฅ5 teeth. (Periodontitis Stage IV) 8. Furcation involvement Class II or III Moderate ridge defect. \- Exclusion Criteria: * 1\. Pregnancy or lactation. 2. Smoking more than 20 cigarettes. 3. Immuno-inflammatory conditions of the skin and oral mucosa 4. systemic conditions affecting bone turnover and periodontal health status (e.g. endocrine and connective tissue diseases, bisphosphonate antiresorptive therapy, gastrointestinal diseases related to nutrition and mineral metabolism) 5. Periodontal or orthodontic treatment at least 6 months before the start of the study 6. Use of anti-inflammatory and antimicrobial agents within 3 months before sampling Inclusion criteria for healthy group: 1. Systemically healthy patients. 2. Patients with an age range between 16 to 80 years. 3. Patients have a minimum of 20 teeth. 4. Less than 10% bleeding sites with probing depths โ‰ค3 mm. 5. absence of erythema, oedema.
๐Ÿ’Š

What it tests

  • Professional mechanical plaque control
๐Ÿ“

Where

2 sites
Faculty of Dentistry-Cairo University
Manial, Egypt
faculty of dentistry Cairo university
Cairo, Egypt
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy